Bruck Kifle

Array ( [id] => 4887680 [patent_doc_number] => 20080262012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 12/119622 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5783 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262012.pdf [firstpage_image] =>[orig_patent_app_number] => 12119622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887692 [patent_doc_number] => 20080262024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'RIFAXIMIN COMPOSITIONS AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 12/119630 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4882 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262024.pdf [firstpage_image] =>[orig_patent_app_number] => 12119630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960600 [patent_doc_number] => 20080275025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Substituted Lactams and Their Use as Anti-Cancer Agents' [patent_app_type] => utility [patent_app_number] => 12/116535 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16034 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275025.pdf [firstpage_image] =>[orig_patent_app_number] => 12116535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823218 [patent_doc_number] => 20080227771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/151545 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1425 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227771.pdf [firstpage_image] =>[orig_patent_app_number] => 12151545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792959 [patent_doc_number] => 20080293933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/110372 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4593 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293933.pdf [firstpage_image] =>[orig_patent_app_number] => 12110372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859160 [patent_doc_number] => 20080268010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'N-ALKYLATED RIFAMPIN' [patent_app_type] => utility [patent_app_number] => 12/109489 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3907 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268010.pdf [firstpage_image] =>[orig_patent_app_number] => 12109489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547015 [patent_doc_number] => 20100222326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders' [patent_app_type] => utility [patent_app_number] => 12/597772 [patent_app_country] => US [patent_app_date] => 2008-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45753 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222326.pdf [firstpage_image] =>[orig_patent_app_number] => 12597772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779424 [patent_doc_number] => 20080287422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Constrained Compounds as CGRP-Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/105434 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61039 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287422.pdf [firstpage_image] =>[orig_patent_app_number] => 12105434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887625 [patent_doc_number] => 20080261957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'DIHYDRO-BENZO[B][1,4]DIAZEPIN-2-ONE SULFONAMIDE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/102140 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9130 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261957.pdf [firstpage_image] =>[orig_patent_app_number] => 12102140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281833 [patent_doc_number] => 07553833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => '3,3-spiroindolinone derivatives' [patent_app_type] => utility [patent_app_number] => 12/101182 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17178 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553833.pdf [firstpage_image] =>[orig_patent_app_number] => 12101182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760091 [patent_doc_number] => 20080312317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => '12 MEMBERED-RING MACROLACTAM DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/100998 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36799 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312317.pdf [firstpage_image] =>[orig_patent_app_number] => 12100998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840371 [patent_doc_number] => 20080280857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/082233 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36976 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280857.pdf [firstpage_image] =>[orig_patent_app_number] => 12082233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92262 [patent_doc_number] => 07732434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Macrocyclic acyl guanidines as beta-secretase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/099334 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14119 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732434.pdf [firstpage_image] =>[orig_patent_app_number] => 12099334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609829 [patent_doc_number] => 07994314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Method for the preparation of an enantiomerically pure benzazepine' [patent_app_type] => utility [patent_app_number] => 12/098677 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10132 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994314.pdf [firstpage_image] =>[orig_patent_app_number] => 12098677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231649 [patent_doc_number] => 20100184741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 12/594815 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27626 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184741.pdf [firstpage_image] =>[orig_patent_app_number] => 12594815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682898 [patent_doc_number] => 20080249124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'WORTMANNIN-RAPALOG CONJUGATE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/061976 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14597 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249124.pdf [firstpage_image] =>[orig_patent_app_number] => 12061976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682897 [patent_doc_number] => 20080249123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'WORTMANNIN-RAPAMYCIN CONJUGATE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/061908 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16179 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249123.pdf [firstpage_image] =>[orig_patent_app_number] => 12061908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570355 [patent_doc_number] => 20090253733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'RAPAMYCIN CARBONATE ESTERS' [patent_app_type] => utility [patent_app_number] => 12/061416 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11637 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253733.pdf [firstpage_image] =>[orig_patent_app_number] => 12061416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860416 [patent_doc_number] => 20080269266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'NOVEL COMPOUNDS 747' [patent_app_type] => utility [patent_app_number] => 12/055658 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16765 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269266.pdf [firstpage_image] =>[orig_patent_app_number] => 12055658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603488 [patent_doc_number] => 20100063013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'CATHEPSIN CYSTEINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/532652 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31685 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063013.pdf [firstpage_image] =>[orig_patent_app_number] => 12532652 [rel_patent_id] =>[rel_patent_doc_number] =>)